CN113842329A - Mouth wash containing swimming nano robot for active prevention and treatment of oral cavity - Google Patents

Mouth wash containing swimming nano robot for active prevention and treatment of oral cavity Download PDF

Info

Publication number
CN113842329A
CN113842329A CN202111004594.XA CN202111004594A CN113842329A CN 113842329 A CN113842329 A CN 113842329A CN 202111004594 A CN202111004594 A CN 202111004594A CN 113842329 A CN113842329 A CN 113842329A
Authority
CN
China
Prior art keywords
swimming
robot
nano
antibacterial
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202111004594.XA
Other languages
Chinese (zh)
Other versions
CN113842329B (en
Inventor
贺强
吴英杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harbin Institute of Technology
Original Assignee
Harbin Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harbin Institute of Technology filed Critical Harbin Institute of Technology
Priority to CN202111004594.XA priority Critical patent/CN113842329B/en
Publication of CN113842329A publication Critical patent/CN113842329A/en
Application granted granted Critical
Publication of CN113842329B publication Critical patent/CN113842329B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22Peroxides; Oxygen; Ozone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43Guanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8129Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers or esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers, e.g. polyvinylmethylether
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90Block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00Manufacture or treatment of nanostructures
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Manufacturing & Machinery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses mouthwash containing a swimming nano robot for active prevention and treatment of an oral cavity, and relates to mouthwash containing the swimming nano robot. The invention aims to solve the problems that the existing mouthwash is not active, the antibacterial drug locally applied in the mouthwash cannot reach the deep and narrow periodontal pocket bottom, and the existing nano robot is used in the mouthwash, or the efficient driving is difficult to realize, or the preparation process is complicated. The mouth wash containing the swimming nano robot for active prevention and treatment of the oral cavity comprises a component A and a component B, wherein the component A consists of hydrogen peroxide, alcohol, glycerol, carboxymethyl cellulose, sodium lauryl sulfate and the balance of ultrapure water; the component B is an aqueous solution containing a swimming nano robot. The invention is used for the mouth wash containing the swimming nano robot and used for the active prevention and treatment of the oral cavity.

Description

Mouth wash containing swimming nano robot for active prevention and treatment of oral cavity
Technical Field
The invention relates to a mouth wash containing a swimming nano robot.
Background
Periodontal disease is an inflammatory disease caused by the accumulation of plaque, which if left uncontrolled results in loss of gingival attachment, formation of periodontal pockets, alveolar bone resorption, and ultimately, tooth loosening and even loss. Periodontal disease has become the leading cause of tooth loss in adults today, and severely affects people's health and quality of life. Currently, the toothpaste and the mouthwash which are used most frequently when people clean the oral cavity in daily life are used, and in recent years, the consumption of the mouthwash in people is higher and higher, and the use frequency is increased year by year. However, at present, most of pathogenic bacteria are located in the periodontal pocket or deep part of gingiva, the existing mouthwash cannot effectively permeate and remove the pathogenic bacteria, and the antibacterial effective components cannot reach the deep and narrow periodontal pocket bottom, so that the using effect of the mouthwash is affected.
The swimming nano robot has the core advantages of additional self-driving force, autonomous navigation, drug loading and controllable release capacity and the like, is expected to greatly improve the targeted drug delivery efficiency, and shows great potential in the aspect of biomedicine. If the swimming nano robot moves effectively and autonomously in gingival crevicular fluid, saliva and other different biological media, an important research method and an implementation means can be provided for the delivery of the periodontal targeted drug of the anti-inflammatory active ingredient, and the swimming nano robot has important significance for improving the prevention and treatment effects of the oral periodontal disease. However, the existing glucose oxidase and urease driven nano-robots have good biocompatibility, but mainly depend on an autophoretic driving mechanism, are greatly influenced by electrolytes in a solution, are difficult to realize high-efficiency driving in body fluid (saliva, gingival crevicular fluid and the like), and cannot reach the bottom of a deep and narrow periodontal pocket, and the existing catalase driven swimming nano-robots cannot realize large-scale industrial application at present due to the complexity of a preparation process.
Disclosure of Invention
The invention aims to solve the problems that the existing mouthwash is not active, the antibacterial drug locally applied in the mouthwash cannot reach the deep and narrow periodontal pocket bottom, and the existing nano robot is used in the mouthwash, or the efficient driving is difficult to realize, or the preparation process is complicated, so that the mouthwash containing the swimming nano robot for the active prevention and treatment of the oral cavity is further provided.
A mouth wash containing a swimming nano robot for active prevention and treatment of oral cavity comprises a component A and a component B, wherein the volume ratio of the component A to the component B is (5-10): 1; the component A consists of 0.5 to 3 percent of hydrogen peroxide, 3 to 5 percent of alcohol, 3 to 5 percent of glycerin, 0.1 to 0.3 percent of carboxymethyl cellulose, 0.01 to 0.03 percent of lauryl sodium sulfate and the balance of ultrapure water according to mass percentage; the component B is 0.5 to 1 mass percent of water solution containing a swimming nano robot; the alcohol is sorbitol or sorbitol;
the swimming nano robot consists of an antibacterial anti-inflammatory drug, a hollow capsule-shaped framework and an enzyme catalyst, wherein the antibacterial anti-inflammatory drug is coated inside the hollow capsule-shaped framework, and the enzyme catalyst is positioned on one side of the hollow capsule-shaped framework; the diameter of the hollow saccular skeleton is 300 nm-100 μm.
The invention has the beneficial effects that:
the invention relates to a functional mouthwash containing a catalase-driven swimming micro-nano robot. The low-concentration hydrogen peroxide in the mouthwash is used as a fuel, the swimming micro-nano robot carries and enriches antibacterial ingredients to the deep of periodontal pockets and gingiva efficiently while performing self-driven rapid movement, and continuous and efficient inhibition of periodontitis pathogenic bacteria is achieved. Compared with the prior art, the enzyme-driven swimming nano robot in the mouthwash has better biocompatibility and biodegradability, simple preparation process and can realize industrial batch production. The swimming nano robot generates bubble drive by decomposing hydrogen peroxide, has stronger driving force, is less influenced by electrolyte, can realize high-efficiency drive in body fluid, obviously improves the using effect of the obtained mouthwash, and is safe and efficient functional mouthwash.
The invention is used for the mouth wash containing the swimming nanometer robot and used for the active prevention and treatment of the oral cavity.
Drawings
FIG. 1 is a diagram of a mouth wash containing a swimming nano-robot for active prevention and treatment of oral cavity according to the present invention;
FIG. 2 is a schematic diagram of a mouth wash containing a swimming nano-robot for active prevention and treatment of oral cavity according to the present invention;
FIG. 3 is a scanning electron microscope image of the flying nano-robot prepared in the first embodiment;
FIG. 4 is a diagram of the movement of the swimming nano-robot prepared in the first embodiment in a hydrogen peroxide solution with a mass percentage of 1%;
FIG. 5 is a fluorescence microscope image of the antimicrobial test.
Detailed Description
The technical solution of the present invention is not limited to the specific embodiments listed below, and includes any combination of the specific embodiments.
The first embodiment is as follows: specifically, referring to fig. 1 and fig. 2, the mouth wash for active prevention and treatment of oral cavity containing swimming nano-robot in the embodiment comprises a component a and a component B, wherein the volume ratio of the component a to the component B is (5-10): 1; the component A consists of 0.5 to 3 percent of hydrogen peroxide, 3 to 5 percent of alcohol, 3 to 5 percent of glycerin, 0.1 to 0.3 percent of carboxymethyl cellulose, 0.01 to 0.03 percent of lauryl sodium sulfate and the balance of ultrapure water according to mass percentage; the component B is 0.5 to 1 mass percent of water solution containing a swimming nano robot; the alcohol is sorbitol or sorbitol;
the swimming nano robot consists of an antibacterial anti-inflammatory drug, a hollow capsule-shaped framework and an enzyme catalyst, wherein the antibacterial anti-inflammatory drug is coated inside the hollow capsule-shaped framework, and the enzyme catalyst is positioned on one side of the hollow capsule-shaped framework; the diameter of the hollow saccular skeleton is 300 nm-100 μm.
The component A and the component B in the embodiment are respectively filled and packaged to obtain a finished product.
The purpose of the present embodiment is to provide a mouth wash containing a swimming nano robot, which has efficient effects of preventing and treating periodontal diseases based on active drug targeting delivery of the swimming nano robot.
The swimming nano robot of the specific embodiment has biocompatibility and biodegradability. The preparation method is characterized in that a polymer with biocompatibility and biodegradability, gold and enzyme are selected as assembly materials to prepare the nano-composite material.
Firstly, preparing a drug-loaded microsphere coated by a biocompatible polymer shell by adopting an oil-in-water-solvent volatilization method;
secondly, modifying gold nanoshells on one side of the drug-loaded microspheres obtained in the second step by a micro-contact printing or vacuum sputtering method;
and thirdly, modifying the gold surface by using a cross-linking agent, and cross-linking catalase on the gold surface by using a covalent cross-linking method to obtain the drug-loaded swimming nano robot with one modified side with the enzyme catalyst.
The principle is as follows: compared with the swimming nano robot driven by autophoresis, the catalase driving swimming nano robot of the embodiment generates bubbles through decomposing hydrogen peroxide to drive movement, has stronger driving force, is less influenced by electrolyte, and can realize high-efficiency driving in body fluid (saliva, gingival crevicular fluid and the like). The swimming nanometer machine of the specific embodiment has better biocompatibility and biodegradability, and the hollow capsule cavity can realize the efficient loading of the antibacterial components.
The swimming nano robot enzyme catalyst is positioned on one side of the hollow capsule-shaped framework, and the swimming nano robot can realize chemical driving movement through chemical reaction due to the asymmetric distribution of the catalyst. During the use, through mixing AB component to low concentration hydrogen peroxide in the mouthwash is the fuel, and the medicine carrying moves about nanometer robot catalysis hydrogen peroxide and produces oxygen and carry out autonomous movement, carries the high-efficient carrier of antibacterial component, enriches to periodontal pocket and gum depths when carrying out the self-driven quick motion, reaches and lasts high-efficient suppression to periodontitis pathogenic bacteria ground.
The beneficial effects of the embodiment are as follows:
the embodiment relates to functional mouthwash containing a catalase-driven swimming micro-nano robot. The low-concentration hydrogen peroxide in the mouthwash is used as a fuel, the swimming micro-nano robot carries and enriches antibacterial ingredients to the deep of periodontal pockets and gingiva efficiently while performing self-driven rapid movement, and continuous and efficient inhibition of periodontitis pathogenic bacteria is achieved. Compared with the prior art, the enzyme-driven swimming nano robot in the mouthwash of the embodiment has better biocompatibility and biodegradability, the preparation process is simple, and industrial batch production can be realized. The swimming nano robot generates bubble drive by decomposing hydrogen peroxide, has stronger driving force, is less influenced by electrolyte, can realize high-efficiency drive in body fluid, obviously improves the using effect of the obtained mouthwash, and is safe and efficient functional mouthwash.
The second embodiment is as follows: the first difference between the present embodiment and the specific embodiment is: the hollow saccular skeleton is formed by biocompatible and degradable high molecular polymer; the biocompatible and degradable high molecular polymer is polyvinyl alcohol, polyethylene glycol amphiphilic block polymer, glucan and chitosan. The rest is the same as the first embodiment.
The third concrete implementation mode: this embodiment is different from the first or second embodiment in that: the enzyme catalyst is catalase, peroxidase, platinum nanoparticles or ferroferric oxide nanoparticles. The other is the same as in the first or second embodiment.
The fourth concrete implementation mode: the difference between this embodiment mode and one of the first to third embodiment modes is: the antibacterial and anti-inflammatory drug is chlorhexidine, fluosilicic acid or sodium fluosilicate. The others are the same as the first to third embodiments.
The fifth concrete implementation mode: the difference between this embodiment and one of the first to fourth embodiments is: when the biocompatible and degradable high molecular polymer is polyethylene glycol-polylactic acid amphiphilic triblock copolymer and the enzyme catalyst is catalase, the swimming nano robot is prepared by the following steps:
dissolving a polyethylene glycol-polylactic acid amphiphilic triblock copolymer in a solvent and uniformly mixing to obtain an organic phase mixed solution, adding the organic phase mixed solution into an aqueous solution containing polyvinyl alcohol and an antibacterial and anti-inflammatory drug, stirring and emulsifying for 30-60 min under the condition that the rotation speed is 500-1000 rpm to obtain an emulsified solution, adding the emulsified solution into water, volatilizing the organic solvent for 4-5 h under the condition that the magnetic stirring speed is 500-1000 rpm, filtering, collecting and washing to obtain polymer microspheres loaded with antibacterial active ingredients;
the mass-to-volume ratio of the polyethylene glycol-polylactic acid amphiphilic triblock copolymer to the solvent is 1g (50-100) mL; the mass percentage of the polyvinyl alcohol in the aqueous solution containing the polyvinyl alcohol and the antibacterial and anti-inflammatory drug is 5-10%; the volume ratio of the organic phase mixed solution to the aqueous solution containing the polyvinyl alcohol and the antibacterial and anti-inflammatory drugs is 1: 1;
dispersing polymer microspheres loaded with antibacterial active ingredients in deionized water to obtain microsphere dispersion liquid, dropwise adding the microsphere dispersion liquid on a hydrophilic substrate, standing for 10-18 h, naturally spreading into single-layer particles, then semi-modifying gold nanoshells on one side of the surfaces of the microspheres by a vacuum sputtering method under the condition that the current is 20-30 mA, sputtering for 2-3 min to obtain gold-modified microspheres, washing the gold-modified microspheres from the hydrophilic substrate by deionized water, and centrifuging for 2-5 min under the condition that the rotating speed is 4000-8000 r/min to obtain the drug-loaded Au-Janus nano robot;
thirdly, placing the drug-loaded Au-Janus nano robot in PBS buffer solution containing N-hydroxyl thiosuccinimide and 1- (3-dimethylaminopropyl) -3-ethyl carbodiimide hydrochloride, processing for 12-24 h, cleaning, placing in catalase solution with the concentration of 1-2 mg/mL, incubating for 12-18 h at the temperature of 37 ℃, and finally cleaning and storing for later use to obtain the swimming nano robot;
the concentration of the N-hydroxy thiosuccinimide in the PBS buffer solution containing the N-hydroxy thiosuccinimide and the 1- (3-dimethylaminopropyl) -3-ethyl carbodiimide hydrochloride is 100 mmol/L-200 mmol/L, and the concentration of the 1- (3-dimethylaminopropyl) -3-ethyl carbodiimide hydrochloride is 300 mmol/L-600 mmol/L. The rest is the same as the first to fourth embodiments.
The polyethylene glycol-polylactic acid amphiphilic triblock copolymer is PLLA100-PEG50-PLLA100
The sixth specific implementation mode: the difference between this embodiment and one of the first to fifth embodiments is: the solvent in the step I is a mixed solution of dichloromethane and acetone, wherein the volume ratio of dichloromethane to acetone is 1 (1-2). The rest is the same as the first to fifth embodiments.
The seventh embodiment: the difference between this embodiment and one of the first to sixth embodiments is: the mass percentage of the antibacterial and anti-inflammatory drug in the aqueous solution containing the polyvinyl alcohol and the antibacterial and anti-inflammatory drug is 5-10%. The others are the same as the first to sixth embodiments.
The specific implementation mode is eight: the present embodiment differs from one of the first to seventh embodiments in that: the volume ratio of the emulsified solution to water in the step I is 1 (5-10). The rest is the same as the first to seventh embodiments.
The specific implementation method nine: the present embodiment differs from the first to eighth embodiments in that: the concentration of the microsphere dispersion liquid in the step II is 0.1 mg/mL-0.5 mg/mL. The other points are the same as those in the first to eighth embodiments.
The detailed implementation mode is ten: the present embodiment differs from one of the first to ninth embodiments in that: the pH value of the PBS buffer solution containing the N-hydroxy thiosuccinimide and the 1- (3-dimethylaminopropyl) -3-ethyl carbodiimide hydrochloride in the step (c) is 7-7.5; washing for three times by using PBS (phosphate buffer solution) with the pH value of 7-7.5 and the concentration of 0.1-0.5 mol/L; the storage for standby use in the step (III) is to store in PBS buffer solution with the temperature of 2-4 ℃. The other points are the same as those in the first to ninth embodiments.
The following examples were used to demonstrate the beneficial effects of the present invention:
the first embodiment is as follows:
a mouth wash containing a swimming nano robot for active prevention and treatment of oral cavity comprises 450mL of component A and 50mL of component B; the component A consists of 0.5 percent of hydrogen peroxide, 5 percent of sorbitol, 5 percent of glycerin, 0.1 percent of carboxymethyl cellulose, 0.01 percent of sodium lauryl sulfate and the balance of ultrapure water according to mass percentage; the component B is 1% of water solution containing a swimming nano robot in percentage by mass;
the swimming nano robot consists of an antibacterial anti-inflammatory drug, a hollow capsule-shaped framework and an enzyme catalyst, wherein the antibacterial anti-inflammatory drug is coated inside the hollow capsule-shaped framework, and the enzyme catalyst is positioned on one side of the hollow capsule-shaped framework; the diameter of the hollow saccular skeleton is 2 μm.
And respectively filling and packaging the component A and the component B to obtain a finished product.
The hollow saccular skeleton is formed by biocompatible and degradable high molecular polymer; the biocompatible and degradable high molecular polymer is polyethylene glycol-polylactic acid amphiphilic triblock copolymer (PLLA)100-PEG50-PLLA100) The enzyme catalyst is catalase, and the antibacterial and anti-inflammatory drug is chlorhexidine; the swimming nano robot is prepared by the following steps:
dissolving 2g of polyethylene glycol-polylactic acid amphiphilic triblock copolymer in 200mL of solvent and uniformly mixing to obtain organic phase mixed solution, adding the organic phase mixed solution into 200mL of aqueous solution containing polyvinyl alcohol and antibacterial and anti-inflammatory drugs, stirring and emulsifying for 40min at the rotation speed of 1000rpm to obtain emulsified solution, adding the emulsified solution into 2000mL of water, volatilizing the organic solvent for 5h at the magnetic stirring speed of 800rpm, collecting microspheres by a filtration method, washing for three times by distilled water to obtain polymer microspheres loaded with antibacterial active ingredients, and storing in ultrapure water;
the solvent is a mixed solution of dichloromethane and acetone in a volume ratio of 1: 1; the mass percentage of the polyvinyl alcohol in the aqueous solution containing the polyvinyl alcohol and the antibacterial and anti-inflammatory drug is 10 percent; the mass percentage of the antibacterial and anti-inflammatory drug in the aqueous solution containing the polyvinyl alcohol and the antibacterial and anti-inflammatory drug is 5 percent;
dispersing polymer microspheres loaded with antibacterial active ingredients in deionized water to obtain microsphere dispersion liquid, dropwise adding the microsphere dispersion liquid on a hydrophilic substrate, standing for 10 hours, naturally spreading into single-layer particles, then semi-modifying gold nanoshells on one side of the surfaces of the microspheres by a vacuum sputtering method under the condition that the current is 30mA, wherein the sputtering time is 3min to obtain gold-modified microspheres, washing the gold-modified microspheres from the hydrophilic substrate by using the deionized water, and centrifuging for 2min under the condition that the rotating speed is 4500r/min to obtain the medicine-carrying Au-Janus nano robot;
thirdly, placing the drug-loaded Au-Janus nano robot into PBS buffer solution containing N-hydroxy thiosuccinimide and 1- (3-dimethylaminopropyl) -3-ethyl carbodiimide hydrochloride, processing for 12 hours, washing, placing into catalase solution with the concentration of 2mg/mL, incubating for 12 hours at the temperature of 37 ℃, finally washing and storing for later use to obtain the swimming nano robot;
the concentration of the N-hydroxy thiosuccinimide in the PBS buffer solution containing the N-hydroxy thiosuccinimide and the 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride is 100mmol/L, and the concentration of the 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride is 400 mmol/L;
the concentration of the microsphere dispersion liquid in the step two is 0.1 mg/mL;
the pH value of the PBS buffer solution containing the N-hydroxy thiosuccinimide and the 1- (3-dimethylaminopropyl) -3-ethyl carbodiimide hydrochloride in the step (c) is 7.2; washing for three times by using PBS (phosphate buffer solution) with the pH value of 7.2 and the concentration of 0.1 mol/L; and the storage for standby in the step (III) is to store in PBS buffer solution with the temperature of 4 ℃ for standby.
Fig. 3 is a scanning electron microscope image of the swimming nano-robot prepared in the first embodiment, and it can be known from the image that the drug-loaded nano-robot prepared in the first embodiment has a uniform size and a complete structure, catalase is modified on one side of the nano-robot, and the asymmetric distribution of the enzyme can provide a high-efficiency self-driving force for the nano-robot.
Fig. 4 is a diagram illustrating the movement of the swimming nano-robot prepared in the first embodiment in a hydrogen peroxide solution with a mass percentage of 1%. As can be seen from the figure, the drug-loaded nano-robot prepared in the first embodiment has the autonomous movement capability, and can decompose the substrate in the low hydrogen peroxide solution through the enzyme catalytic reaction to enhance diffusion.
Control group: the contrast group differs from the first example in that: the same concentration of the antibacterial drug was dissolved directly in water to give component B, otherwise the same as in example one.
1. Evaluation of antibacterial performance of mouthwash:
to qualitatively evaluate the efficacy of the mouthwash prepared in this example, the antibacterial performance of porphyromonas gingivalis was evaluated. The mouthwash prepared in the first embodiment is used as an experimental group, the mouthwash without a drug-loaded swimming nano robot is used as a control group, and is co-cultured with porphyromonas gingivalis respectively, and the antibacterial performance of the mouthwash is tested by using calcein and Pi double-dying live bacteria. Calcein-stained live bacteria are green, while Pi-stained dead bacteria are red. FIG. 5 is a fluorescence microscope image of the antibacterial test, and it can be seen that after 24 hours of co-culture, the positive fluorescence microscope observation shows that a large number of pi-stained bacteria in the experimental group appear red, almost one hundred percent of Porphyromonas gingivalis are killed, while the control group has only forty percent of sterilization rate, indicating that the mouthwash has obvious antibacterial activity. The researches show that the mouthwash added with the medicine-carrying swimming nanometer machine has good antibacterial activity and can maintain the micro-ecological stability of the oral cavity.
2. Evaluation of the efficacy of the mouthwash:
the mouthwash prepared in the first example is used as an experimental group, and the mouthwash without a drug-loaded swimming nano robot is used as a control group for 20 patients with mild periodontitis respectively, and the using method comprises the following steps: after rinsing with clear water, rinsing with mouthwash for 20 seconds; the medicine is used once in the morning and at night every day, and is continuously used for seven days, and each observation index of a patient is counted: and detecting the periodontal probing depth, the plaque index and the gingival sulcus bleeding index of the patient. The results of the analysis using the SPSS22.0 statistical software are shown in table 1 below. After one week of use, the periodontal probing depth, plaque index and gingival sulcus bleeding index of the experimental group were lower than those of the control group, and the difference was statistically significant (P < 0.05). The mouthwash prepared by the embodiment has good safety and certain effect, and can improve the periodontal health index of patients and reduce inflammatory reaction.
TABLE 1
Figure BDA0003236718440000071

Claims (10)

1. A mouth wash containing a swimming nano robot for active prevention and treatment of oral cavity is characterized by comprising a component A and a component B, wherein the volume ratio of the component A to the component B is (5-10) to 1; the component A consists of 0.5 to 3 percent of hydrogen peroxide, 3 to 5 percent of alcohol, 3 to 5 percent of glycerin, 0.1 to 0.3 percent of carboxymethyl cellulose, 0.01 to 0.03 percent of lauryl sodium sulfate and the balance of ultrapure water according to mass percentage; the component B is 0.5 to 1 mass percent of water solution containing a swimming nano robot; the alcohol is sorbitol or sorbitol;
the swimming nano robot consists of an antibacterial anti-inflammatory drug, a hollow capsule-shaped framework and an enzyme catalyst, wherein the antibacterial anti-inflammatory drug is coated inside the hollow capsule-shaped framework, and the enzyme catalyst is positioned on one side of the hollow capsule-shaped framework; the diameter of the hollow saccular skeleton is 300 nm-100 μm.
2. The mouthwash containing the swimming nanomachines for active oral prevention and treatment according to claim 1, wherein the hollow saccular skeleton is formed of a biocompatible and degradable high molecular polymer; the biocompatible and degradable high molecular polymer is polyvinyl alcohol, polyethylene glycol amphiphilic block polymer, glucan and chitosan.
3. The mouthwash containing the swimming nanotechnology for active prevention and treatment of the oral cavity according to claim 1, wherein the enzyme catalyst is catalase, peroxidase, platinum nanoparticles or ferroferric oxide nanoparticles.
4. The mouthwash containing the swimming nano-robot for the active prevention and treatment of the oral cavity according to claim 1, wherein the antibacterial and anti-inflammatory drug is chlorhexidine, fluosilicic acid or sodium fluosilicate.
5. The mouthwash according to claim 1, wherein when the biocompatible and degradable polymer is polyethylene glycol-polylactic acid amphiphilic triblock copolymer and the enzyme catalyst is catalase, the swimming nanotechnology is prepared by the following steps:
dissolving a polyethylene glycol-polylactic acid amphiphilic triblock copolymer in a solvent and uniformly mixing to obtain an organic phase mixed solution, adding the organic phase mixed solution into an aqueous solution containing polyvinyl alcohol and an antibacterial and anti-inflammatory drug, stirring and emulsifying for 30-60 min under the condition that the rotation speed is 500-1000 rpm to obtain an emulsified solution, adding the emulsified solution into water, volatilizing the organic solvent for 4-5 h under the condition that the magnetic stirring speed is 500-1000 rpm, filtering, collecting and washing to obtain polymer microspheres loaded with antibacterial active ingredients;
the mass-to-volume ratio of the polyethylene glycol-polylactic acid amphiphilic triblock copolymer to the solvent is 1g (50-100) mL; the mass percentage of the polyvinyl alcohol in the aqueous solution containing the polyvinyl alcohol and the antibacterial and anti-inflammatory drug is 5-10%; the volume ratio of the organic phase mixed solution to the aqueous solution containing the polyvinyl alcohol and the antibacterial and anti-inflammatory drugs is 1: 1;
dispersing polymer microspheres loaded with antibacterial active ingredients in deionized water to obtain microsphere dispersion liquid, dropwise adding the microsphere dispersion liquid on a hydrophilic substrate, standing for 10-18 h, naturally spreading into single-layer particles, then semi-modifying gold nanoshells on one side of the surfaces of the microspheres by a vacuum sputtering method under the condition that the current is 20-30 mA, sputtering for 2-3 min to obtain gold-modified microspheres, washing the gold-modified microspheres from the hydrophilic substrate by deionized water, and centrifuging for 2-5 min under the condition that the rotating speed is 4000-8000 r/min to obtain the drug-loaded Au-Janus nano robot;
thirdly, placing the drug-loaded Au-Janus nano robot in PBS buffer solution containing N-hydroxyl thiosuccinimide and 1- (3-dimethylaminopropyl) -3-ethyl carbodiimide hydrochloride, processing for 12-24 h, cleaning, placing in catalase solution with the concentration of 1-2 mg/mL, incubating for 12-18 h at the temperature of 37 ℃, and finally cleaning and storing for later use to obtain the swimming nano robot;
the concentration of the N-hydroxy thiosuccinimide in the PBS buffer solution containing the N-hydroxy thiosuccinimide and the 1- (3-dimethylaminopropyl) -3-ethyl carbodiimide hydrochloride is 100 mmol/L-200 mmol/L, and the concentration of the 1- (3-dimethylaminopropyl) -3-ethyl carbodiimide hydrochloride is 300 mmol/L-600 mmol/L.
6. The mouth wash containing the swimming nano-robot for active prevention and treatment of the oral cavity according to claim 5, wherein the solvent in the step (r) is a mixed solution of dichloromethane and acetone, and the volume ratio of the dichloromethane to the acetone is 1 (1-2).
7. The mouth wash containing the swimming nano-robot for active prevention and treatment of the oral cavity according to claim 5, wherein the mass percentage of the antibacterial and anti-inflammatory drug in the aqueous solution containing the polyvinyl alcohol and the antibacterial and anti-inflammatory drug in the step (r) is 5-10%.
8. The mouth wash containing the swimming nano-robot for active prevention and treatment of the oral cavity according to claim 5, characterized in that the volume ratio of the emulsified solution to water in the step (r) is 1 (5-10).
9. The mouthwash containing the swimming nano-robot for active prevention and treatment of the oral cavity according to claim 5, wherein the concentration of the microsphere dispersion in the step (II) is 0.1mg/mL to 0.5 mg/mL.
10. The mouth wash containing the swimming nano-robot for active prevention and treatment of the oral cavity according to claim 5, wherein the pH of the PBS buffer solution containing the N-hydroxy thiosuccinimide and the 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride in the step (c) is 7-7.5; washing for three times by using PBS (phosphate buffer solution) with the pH value of 7-7.5 and the concentration of 0.1-0.5 mol/L; the storage for standby use in the step (III) is to store in PBS buffer solution with the temperature of 2-4 ℃.
CN202111004594.XA 2021-08-30 2021-08-30 Mouth wash containing swimming nano robot for active prevention and treatment of oral cavity Active CN113842329B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111004594.XA CN113842329B (en) 2021-08-30 2021-08-30 Mouth wash containing swimming nano robot for active prevention and treatment of oral cavity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111004594.XA CN113842329B (en) 2021-08-30 2021-08-30 Mouth wash containing swimming nano robot for active prevention and treatment of oral cavity

Publications (2)

Publication Number Publication Date
CN113842329A true CN113842329A (en) 2021-12-28
CN113842329B CN113842329B (en) 2023-04-14

Family

ID=78976511

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111004594.XA Active CN113842329B (en) 2021-08-30 2021-08-30 Mouth wash containing swimming nano robot for active prevention and treatment of oral cavity

Country Status (1)

Country Link
CN (1) CN113842329B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117018210A (en) * 2023-04-23 2023-11-10 国科温州研究院(温州生物材料与工程研究所) Swimming cell robot and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675547A (en) * 2011-03-09 2012-09-19 中国科学院化学研究所 Janus particle with double properties and preparation method thereof
KR20160047793A (en) * 2014-10-23 2016-05-03 명지대학교 산학협력단 Manufacturing method for janus particle, manufacturing method for antibacterial janus particles using the method and antibacterial janus particles
CN110478247A (en) * 2019-08-27 2019-11-22 哈尔滨工业大学 A kind of micro-nano motor capsule and preparation method thereof
CN111575267A (en) * 2020-05-06 2020-08-25 吕梁学院 Artificial micro-nano robot and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675547A (en) * 2011-03-09 2012-09-19 中国科学院化学研究所 Janus particle with double properties and preparation method thereof
KR20160047793A (en) * 2014-10-23 2016-05-03 명지대학교 산학협력단 Manufacturing method for janus particle, manufacturing method for antibacterial janus particles using the method and antibacterial janus particles
CN110478247A (en) * 2019-08-27 2019-11-22 哈尔滨工业大学 A kind of micro-nano motor capsule and preparation method thereof
CN111575267A (en) * 2020-05-06 2020-08-25 吕梁学院 Artificial micro-nano robot and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PAULA DÍEZ,ET AL: "Ultrafast Directional Janus Pt−Mesoporous Silica Nanomotors for Smart Drug Delivery" *
林显坤等: "可控分子组装的自驱动胶体马达及其生物医学应用" *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117018210A (en) * 2023-04-23 2023-11-10 国科温州研究院(温州生物材料与工程研究所) Swimming cell robot and preparation method thereof
CN117018210B (en) * 2023-04-23 2024-05-07 国科温州研究院(温州生物材料与工程研究所) Swimming cell robot and preparation method thereof

Also Published As

Publication number Publication date
CN113842329B (en) 2023-04-14

Similar Documents

Publication Publication Date Title
CN101498061B (en) Method for improving antibiosis of silk fibroin material
CN113842329B (en) Mouth wash containing swimming nano robot for active prevention and treatment of oral cavity
CN109820821B (en) Oral care solution capable of effectively inhibiting bacteria
EP0746303A1 (en) Stabilized enzymatic antimicrobial compositions
Zhu et al. Functional nanomaterials and their potentials in antibacterial treatment of dental caries
CN1688280A (en) Antiplaque enzyme containing dual component composition
CN115068369B (en) Cation matrix slow-release system and preparation method and application thereof
CN114425089B (en) Yeast bionic micro-nano biological robot and preparation method thereof
CN111602672A (en) Antibacterial nano material and preparation method and application thereof
CN102362861A (en) Hollow composite nanoparticle with core-shell structure and preparation method thereof
CN112716812B (en) Biofilm-resistant remineralizing material for root canal flushing and blocking treatment of dentinal caries and preparation method thereof
Yin et al. Rational designs of biomaterials for combating oral biofilm infections
CN115444834B (en) Fusion cell membrane coated uricase and superparamagnetism ferric oxide nano enzyme lipid nanoparticle and preparation method thereof
CN114984211A (en) Novel nanoparticles, preparation method and application thereof
CN115006530B (en) Composite material for resisting bacteria, removing bacterial biofilm and/or preventing dental caries, and preparation method and application thereof
CN106924090A (en) A kind of preparation and application of the immobilized lysozyme toothpaste of multistage hole bioactive glass
CN114712501B (en) Preparation method and application of nanocomposite for treating periodontitis by ultrasound
CN114652637B (en) Nanometer preparation based on cationic hydroxyapatite, preparation, application, pharmaceutical composition, spray, mouthwash and hydrogel
Cheng et al. Tailoring Biomaterials Ameliorate Inflammatory Bone Loss
Liao et al. Stimuli-responsive graphdiyne-silver nanozymes for catalytic ion therapy of dental caries through targeted biofilms removal and remineralization
CN113576942B (en) Anti-sugar toothpaste and preparation method thereof
CN111870737B (en) Preparation method of titanium alloy-based antibacterial film
Nurdin et al. Synthesis and characterization of silica microcapsules with active compounds 2% chlorhexidine using sodium alginate and chitosan coating as medicament of root canal infection
CN114504647B (en) Hydrogel and preparation method and application thereof
US20230122688A1 (en) Method for preparing polydopamine nanomotor using urease, and use of same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant